title: Double-blind study of true vs. sham plasmapheresis in patients being treated with immunosuppression for acute attacks of multiple sclerosis.
authors.forename: H L
authors.initials: HL
authors.lastname: Weiner
authors.forename: P C
authors.initials: PC
authors.lastname: Dau
authors.forename: B O
authors.initials: BO
authors.lastname: Khatri
authors.forename: J
authors.initials: J
authors.lastname: Petajan
authors.forename: G
authors.initials: G
authors.lastname: Birnbaum
authors.forename: M P
authors.initials: MP
authors.lastname: McQuillen
authors.forename: M T
authors.initials: MT
authors.lastname: Fosburg
authors.forename: M
authors.initials: M
authors.lastname: Feldstein
authors.forename: J
authors.initials: J
authors.lastname: Orav
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004311:Double-Blind Method; D006801:Humans; D007165:Immunosuppression Therapy; D015337:Multicenter Studies as Topic; D009103:Multiple Sclerosis / Q000628:therapy*; D010956:Plasmapheresis; D016032:Randomized Controlled Trials as Topic
chemical_list: D003520:Cyclophosphamide; D000324:Adrenocorticotropic Hormone